Feb 12 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:
ILLUCCIX® APPROVED IN THE UNITED KINGDOM
Source text: ID:nGNX2cjTDn
Further company coverage: TLX.AX
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.